Skip Ribbon Commands
Skip to main content
SharePoint

News Articles

Manage PermissionsManage Permissions

Title

Run Date

Media Outlet

Abstract

Physicians and patients are warming up to biosimilars but policy tweaks are needed to boost utilization, industry observers said. Around three-quarters of physicians see biosimilars as equally safe and effective as their corresponding biologic and 71% of patients are willing to take them with a doctor's recommendation, according to a new NORC at the University of Chicago survey of more than 1,200 physicians and patients. But the therapies' adoption has been slowed by price manipulation and patent litigation.

External Link

Thumbnail Image

 

DataEnclave

NORCCapabilityTags

NORCDepartmentTags

NORCExpertTags

NORCProjectTags

NORCTopicTags

NORCSortDate

Attachments

Content Type: NORC News Article
Created at by
Last modified at by